comparemela.com

Latest Breaking News On - Geoffrey eich - Page 1 : comparemela.com

Attune Ensemble, the app for the well-being of cancer patients, now available in Spanish

Extraordinary news for people with cancer comes from the hand of Blue Note Therapeutics, and the new Spanish-language version of its application.

United statesGeoffrey eichSam haroDanielg garzaPatient servicesPublic health emergencyBlue note therapeuticsAttune ensembleBlue note therapeuticCognitive behavioral stress managementAnal cancer patient advocatePatient advisorBlue noteLatin americanHe app for the well being of cancer patientsOw available in spanish

Attune Ensemble™ OTC, a First-of-Its-Kind Cancer Well-Being

SAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) Blue Note Therapeutics today announced plans to provide Spanish-speaking patients with immediate access.

United statesGeoffrey eichSam haroDanielg garzaKim kingPatient serviceLatino cancer communityPublic health emergencyAmerican cancer societyNational comprehensive cancer networkNote therapeuticsBlue noteBlue note therapeuticBlue note therapeuticsCognitive behavioral stress managementLatin american

Blue Note Therapeutics and Bixink Enter Licensing Agreement

SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the.

South koreaSouth koreanGeoffrey eichMikyoung hahnKim kingDrug administrationBixink therapeutics coNote therapeuticsBixink therapeuticsBlue noteBlue note therapeuticsBreakthrough device designationBreakthrough deviceSouth korean bio companyDigital therapeuticsMental health

Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription

SAN FRANCISCO - May 9, 2022 - (Newswire.com) Blue Note Therapeutics and Bixink Therapeutics, a bio-subsidiary of KPS, today announced that the companies have entered into an exclusive lic.

South koreaSouth koreanGeoffrey eichMikyoung hahnKim kingDrug administrationBixink therapeutics coNote therapeuticsBixink therapeuticsBlue noteBlue note therapeuticsBreakthrough device designationBreakthrough deviceSouth korean bio companyRelease serviceBixink enter licensing agreement

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

/PRNewswire/ Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics.

United statesPrnewswire curebaseGeoffrey eichKim kingTom lembergShawn malloyCenters for diseaseDrug administrationAmerican cancer societyNational comprehensive cancer networkBlue note therapeuticsBlue noteBlue note therapeuticNote therapeuticsPrescription digital therapeuticsCancer facts

vimarsana © 2020. All Rights Reserved.